Accessibility Menu
 
Oculis Ag logo

Oculis Ag

(NASDAQ) OCS

Current Price$27.51
Market Cap$1.57B
Since IPO (2021)+183%
5 YearN/A
1 Year+55%
1 Month+2%

Oculis Ag Financials at a Glance

Market Cap

$1.57B

Revenue (TTM)

$504.00K

Net Income (TTM)

$98.78M

EPS (TTM)

$-2.28

P/E Ratio

-12.05

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$27.51

Volume

3,008

Open

$27.18

Previous Close

$27.51

Daily Range

$26.96 - $27.58

52-Week Range

$16.00 - $30.68

OCS News

No articles available.

OCS: Motley Fool Moneyball Superscore

48

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oculis Ag

Industry

Pharmaceuticals

Employees

60

CEO

Riad Sherif, MD, MBA

Headquarters

Zug, 6300, CH

OCS Financials

Key Financial Metrics (TTM)

Gross Margin

-29%

Operating Margin

-163%

Net Income Margin

-196%

Return on Equity

-72%

Return on Capital

-41%

Return on Assets

-42%

Earnings Yield

-8.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.57B

Shares Outstanding

57.17M

Volume

3.01K

Avg. Volume

351.38K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$79.15M

EBITDA

$79.15M

Operating Cash Flow

$62.22M

Capital Expenditure

$287.47K

Free Cash Flow

$62.51M

Cash & ST Invst.

$213.25M

Total Debt

$2.32M

Oculis Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.57B

N/A

Market Cap/Employee

$32.06M

N/A

Employees

49

N/A

Net Income

$23.34M

+18.6%

EBITDA

$20.88M

+26.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$210.94M

+116.4%

Accounts Receivable

$994.13K

+27.9%

Inventory

$0.00

N/A

Long Term Debt

$1.81M

+109.6%

Short Term Debt

$502.57K

+59.5%

Return on Assets

-41.81%

N/A

Return on Invested Capital

-41.08%

N/A

Free Cash Flow

$16.02M

-53.8%

Operating Cash Flow

$15.98M

-54.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NRIXNurix Therapeutics, Inc.
$16.81+0.66%
NKTRNektar Therapeutics
$86.46+1.67%
URGNUroGen Pharma Ltd.
$23.00-3.48%
PHATPhathom Pharmaceuticals, Inc.
$12.01+7.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About OCS

What is the current price of Oculis Ag?

Oculis Ag is trading at $27.51 per share.

What is the 52-week range for Oculis Ag?

Over the past 52 weeks, Oculis Ag has traded between $16.00 and $30.68.

How much debt does Oculis Ag have?

As of the most recent reporting period, Oculis Ag reported total debt of $2.92M.

How much cash does Oculis Ag have on hand?

Oculis Ag reported $102.66M in cash and cash equivalents in its most recent financial results.

What is Oculis Ag’s dividend yield?

Oculis Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.